FETAX interlaboratory validation study: Phase III - Part 1 testing

Journal of Applied Toxicology

Volumn 16, Issue 6, 1996, Pages 517-528

  Bantle, John A ^a   Finch, Robert A ^b   Burton, Dennis T ^c   Fort, Douglas J ^d   Dawson, Douglas A ^e   Linder, Greg ^f   Rayburn, James R ^a   Hull, Mendi ^a   Kumsher King, Marie ^b   Gaudet Hull, Angela M ^b   Turley, Steven D ^c  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Stover Biometric Laboratories Inc   (United States)

^e ASHLAND UNIVERSITY   (United States)

^f U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

aminoproprionate; Ascorbic acid; Copper sulfate; Developmental toxicity; FETAX; Interlaboratory validation; Monosodium glutamate; Sodium acetate; Sodium arsenate; Teratogen; Xenopus

Indexed keywords

3 AMINOPROPIONITRILE; ACETIC ACID; ARSENATE SODIUM; ASCORBIC ACID; COPPER SULFATE; GLUTAMATE SODIUM;

ACCURACY; ANIMAL CELL; ARTICLE; BIOASSAY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; ECOTOXICOLOGY; EMBRYO; LABORATORY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; STAGING; STANDARDIZATION; TERATOGENESIS; XENOPUS;

AMINOPROPIONITRILE; ANIMALS; ARSENATES; ASCORBIC ACID; COPPER SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; OBSERVER VARIATION; SODIUM ACETATE; SODIUM GLUTAMATE; TERATOGENS; XENOPUS LAEVIS;

ANIMALIA; ANURA; MAMMALIA;

EID: 5644268913     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199611)16:6<517::AID-JAT385>3.0.CO;2-R     Document Type: Article

References (48)

1. J. N. Dumont, T. W. Schultz, M. V. Buchanan and G. L. Kao, Frog embryo teratogenesis assay: Xenopus (FETAX) - a short-term assay applicable to complex environmental mixtures. In Symposium on the Application of Short-Term Bioassays in the Analysis of Complex Environmental Mixtures III, ed. by M. D. Waters, S. S. Sandhu, J. Lewtas, L. Claxton, N. Chernoff and S. Nesnow, pp. 393-405. Plenum Press, New York (1983).
2. J. A. Bantle and D. A. Dawson, Uninduced rat liver microsomes as an in vitro metabolic activation system for the Frog Embryo Teratogenesis Assay - Xenopus (FETAX). In Aquatic Toxicology and Hazard Assessment, vol. 10, ed. by W. J. Adams, G. A. Chapman and W. G. Landis, ASTM STP 971, pp. 316-326. American Society for Testing and Materials, Philadelphia (1988).
3. J. A. Bantle, D. J. Fort and B. L. James, Identification of developmental toxicants using the Frog Embryo Teratogenesis Assay - Xenopus (FETAX). Hydrobiology 188/189, 577-585 (1989).
4. D. A. Dawson, D. J. Fort, G. L. Smith, D. L. Newell and J. A. Bantle, Evaluation of the developmental toxicity of nicotine and cotinine with Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Teratogen. Carcinogen. Mutagen.8, 329-338 (1988).
5. D. J. Fort, D. A. Dawson and J. A. Bantle, Development of a metabolic activation system for the Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Teratogen. Carcinogen. Mutagen. 8, 251-263 (1988).
6. D. J. Fort and J. A. Bantle, Use of Frog Embryo Teratogenesis Assay - Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin. Fundam. Appl. Toxicol. 14, 720-733 (1990).
7. D. J. Fort and J. A. Bantle, Analysis of the mechanism of isoniazid-induced developmental toxicity with the Frog Embryo Teratogenesis Assay - Xenopus (FETAX), Teratogen. Carcinogen. Mutagen. 10, 463-476 (1990).
8. D. J. Fort, J. R. Rayburn, D. J. DeYoung and J. A. Bantle, Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX. Drug Chem. Toxicol. 14, 143-160 (1991).
9. D. J. Fort, J. R. Rayburn and J. A. Bantle, Evaluation of acetaminophen-induced developmental toxicity using FETAX, Drug Chem. Toxicol. 15, 329-350 (1992).
10. J. A. Bantle, FETAX - A developmental toxicity assay using frog embryos. In Fundamentals of Aquatic Toxicology, 2nd Edn, ed. by G. M. Rand, pp. 207-230. Taylor and Francis, Washington, DC (1995).
11. J. N. Dumont and T. W. Schultz, Effects of coal-gasification sour water on Xenopus laevis embryos. J. Environ. Sci. Health A15, 127-138 (1980).
12. D. A. Dawson, C. A. McCormick and J. A. Bantle, Detection of teratogenic substances in acidic mine water samples using the Frog Embryo Teratogenesis Assay - Xenopus (FETAX). J. Appl. Toxicol. 5, 234-244 (1985).
13. D. A. Dawson, E. Stabler, S. A. Burks and J. A. Bantle, Teratogenicity of metal contaminated sediment extracts to frog (Xenopus laevis) and fathead minnow (Pimeph ales promelas) embryos Environ. Toxicol. Chem. 7, 27-34 (1988).
14. J. A. Bantle, D. J. Fort and D. A. Dawson, Bridging the gap from short-term teratogenesis assays to human health hazard assessment by understanding common modes of teratogenic action. In Aquatic Toxicology and Hazard Assessment, Vol. 12, ed. by W. G. Landis and W. H. Van der Schalie, ASTM STP 1096, pp. 46-58. American Society for Testing and Materials, Philadelphia (1989).
15. D. B. Wake and H. J. Morowitz, Declining amphibian populations - a global phenomenon. Report of a workshop sponsored by the Board on Biology, National Research Council, held at Irvine, CA, February 19-20 (1990).
16. D. B. Wake, Declining amphibian populations. Science 253, 860 (1991).
17. J. H. K. Pechman, D. E. Scott, R. D. Semlitsch, J. P. Caldwell, L. J. Vitt and J. W. Gibbons, Declining amphibian populations: the problem of separating human impacts from natural fluctuations. Science 253, 892-895 (1991).
18. Science Briefings, New task force on declining amphibians. Science 253, 509 (1991).
19. American Society for Testing and Materials, New Standard Guide for Conducting the Frog Embryo Teratogenesis Assay - Xenopus (FETAX), ASTM E1439-91. ASTM Special Publications, Philadelphia (1991).
20. J. A. Bantle, J. N. Dumont, R. A. Finch and G. Linder, Atlas of Abnormalities: a Guide for the Performance of FETAX. Oklahoma State Publications Department (1991).
21. J. A. Bantle, D. T. Burton, D. A. Dawson, J. N. Dumont, R. A. Finch, D. J. Fort, G. Linder, J. R. Rayburn, D. Buchwalter, M. A. Maurice and S. D. Turley, Initial interlaboratory validation study of FETAX: Phase I testing. J. Appl. Toxicol. 14, 213-223 (1994).
22. J. A. Bantle, D. T. Burton, D. A. Dawson, J. N. Dumont, R. A. Finch, D. J. Fort, G. Linder, J. R. Rayburn, D. Buchwalter, A. M. Gaudet-Hull, M. A. Maurice and S. D. Turley, Initial interlaboratory validation study of FETAX: Phase II testing. Environ. Toxicol. Chem. 13, 1629-1637 (1994).
23. R. J. Tallarida and R. B. Murray, Manual of Pharmacologic Calculations with Computer Programs, 2nd Edn. Springer-Verlag, New York (1987).
24. M. A. Hamilton, R. C. Russo and R. V. Thurston, Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Environ. Sci. Technol. 11, 714-718 (1977).
25. G. D. Steel and J. H. Torrie, Principles and Procedures of Statistics: a Biometrical Approach, 2nd Edn, ed. by C. Napier and J. W. Maisel. McGraw-Hill Book Company, New York (1980).
26. American Society for Testing and Materials, Standard Practice for Conducting an Interlaboratory Study to Determine the Precision of a Test Method, ASTM E691-87, Annual Book of ASTM Standards, Vol. 14.02, pp. 419-438. ASTM, Philadelphia (1988).
27. B. R. Parkhurst, W. Warren-Hicks and L. E. Noel, Performance characteristics of effluent toxicity tests: summarization and evaluation of data. Environ. Toxicol. Chem. 2, 777-797 (1992).
28. U. Murakami and M. Inouye, Brain lesions in the mouse fetus caused by maternal administration of monosodium glutamate. Congen. Anom. 11, 171-177 (1971).
29. N. J. Adamo and A. Ratner, Monosodium glutamate lack of effects on brain and reproductive function in rats. Science 68, 673-674 (1970).
30. J. W. Olney, Glutamate neuronal necrosis in the infant mouse hypothalmus. An electron microscope study. J. Neuropathol. Exp. Neurol. 30, 75-90 (1971).
31. J. W. Olney, J. Labruyere and T. de Gubareff, Brain damage in mice from voluntary ingestion of glutamate and aspartate. Neurobehav. Toxicol. 2, 125-129 (1981).
32. T. L. The and R. J. Dryden, Monosodium glutamate in the chick embryo: lack of obvious toxic or teratogenic effects when administered at 24 hours incubation. Exp. Pathol. 17, 167-170 (1979).
33. D. J. DeYoung, J. A. Bantle and D. J. Fort, Developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin, and 13-cis retinoic acid tested in FETAX. Drug Chem. Toxicol. 14, 127-141 (1991).
34. P. I. Pillans, S. F. Ponzi and M. I. Parker, Effects of ascorbic acid on the mouse embryo and on cycloprtosphamide-induced cephalic DNA strand breaks in vivo. Arch. Toxic ol. 64, 423-425 (1990).
35. M. T. Colomina, M. Gomez, J. L. Domingo and J. Corbella, Lack of maternal and developmental toxicity given high doses of aluminium hydroxide and ascorbic acid during gestation. Pharmacol. Toxicol. 74, 236-239 (1994).
36. M. N. Simpson, S. J. Freeman and C. E. Steele, Embryotoxic action of β-aminopropionitrile during organogenesis in rats. Mech. Mod. Toxicol.-Arch. Toxicol. 11, 140-142 (1987).
37. M. G. Joneja and M. J. Wiley, Inhibition of β-aminopropionitrile (βAPN)-induced skeletal teratogenesis by the flavoid β-hydroxyethylrutosides (HR) in hamster fetuses. Teratology 26, 59-63 (1982).
38. G. Granstrom, C. Jacobsson and S. Kirkeby, Diagnosis of induced cleft palate in rats from defective patterns of differentiation of isozymes. Scand. J. Plast Reconstr. Surg. Hand. Surg. 26, 13-20 (1992).
39. F. W. Stamler, Reproduction in rats fed lathrus peas or aminonitriles. Proc. Soc. Exp. Biol. Med. 90, 294-298 (1955).
40. A. J. Steffak, A. C. Verrusio and C. A. Watkins, Cleft palate in rodents after maternal treatment with various lathyrogenic agents. Teratology 5, 33-40 (1972).
41. D. J. DeYoung, J. A. Bantle, M. A. Hull and S. L. Burks, Differences in sensitivity to developmental toxicants as seen in Xenopus and Pimephales embryos. Bull. Environ. Contam. Toxicol. 56, 143-150 (1996).
42. M. S. Golub, Maternal toxicity and the identification of inorganic arsenic as a developmental toxicant. Reprod. Toxicol. 8, 283-295 (1994).
43. M. Goldman and J. C. Dacre, Inorganic arsenic compounds: are they carcinogenic, mutagenic, teratogenic? Environ. Geochem. Health 13, 179-192 (1991).
44. J. L. Domingo, Metal-induced developmental toxicity in mammals: a review. J. Toxicol. Environ. Health 42, 123-141 (1994).
45. D. J. Fort and E. L. Stover, Effect of low-level copper and pentachlorophenol exposure on various early life stages of Xenopus laevis. In Environmental Toxicology and Risk Assessment: Biomarkers and Risk Assessment: Fifth Volume, ed. by D. A. Bengston and D. S. Henshel. American Society for Testing and Materials, Philadelphia (1996).
46. R. L. Brinster and P. C. Cross, Effect of copper on the preimplantation mouse embryo. Nature 238, 398-399 (1972).
47. R. W. Mason, I. R. Edwards and L C. Fisher, Teratogenicity of combinations of sodium dichromate, sodium arsenate and copper sulphate in the rat. Comp. Biochem. Physiol. C 93, 407-411 (1989).
48. F. J. DiCarlo, Syndromes of cardiovascular malformations induced by copper citrate in hamsters. Teratology 21, 89-101 (1980).